Aliènne Salleroli on Establishing Equity, Diversity, and Inclusion Throughout Oncology Practice
The framework for establishing equity, diversity, and inclusion throughout oncology nursing already exists within the standard for health and safety, explains Aliènne Salleroli, MS, BSN, RN, OCN.
Michelle Mollica on Individualizing Care Plans for Cancer Survivors
Michelle Mollica, PhD, MPH, RN, OCN, of the National Cancer Institute, discusses how childhood cancer survivors may face different challenges than adult or geriatric patients.
Ilene Galinsky Highlights Evolution of AML Treatment
Ilene Galinsky, BSN, MSN, ANP-C, senior leukemia protocol research nurse practitioner, at Dana Farber Cancer Institute, discusses how treatment for patients with acute myeloid leukemia has evolved in recent years.
Nurse Takeaways: Latest Pembrolizumab Indication in Endometrial Cancer
Courtney Arn, APRN-CNP, a nurse practitioner comments on the recent approval of pembrolizumab for patients with MSI-H/dMMR advanced endometrial carcinoma.
Patients With Cancer May Need Help Changing Their Eating Approaches
Caitlin Benda, MBA, MS, RD, CSO, LDN, a clinical oncology nutritionist supervisor at American Oncology Network, comments on different ways oncology nurses can assist patients in reaching their overall caloric intake.
Expert Talks Significance of Relatlimab/Nivolumab Approval for Metastatic Melanoma
Hussein A. Tawbi, MD, PhD, principal investigator of the phase 2/3 RELATIVITY-046 trial, highlights the importance of relatlimab/nivolumab’s recent FDA approval in melanoma.
Dr. Geyer Highlights Optimal Dosing Strategies for New Olaparib Indication in Breast Cancer
Charles E. Geyer, MD, FACP, discusses dosing strategies and adverse event management with olaparib.
Nurses Can Lead Conversations on Fertility Preservation
As prognoses continue to improve, concerns about treatment-associated fertility risks are becoming more prevalent and are often a topic of discussion between patients and their nurses or nurse practitioners.
Bioimpedance Spectroscopy: How It Functions and How It Improves Subclinical Lymphedema Detection
Sheila L. Ridner, PhD, RN, FAAN, provides an overview of bioimpedance spectroscopy and how the simple design allows for standardized subclinical lymphedema surveillance in breast cancer survivors.
Cyropreservation Continues to Improve Fertility Options for Patients with Breast Cancer
Lindsay Kroener, MD, offers an overview of current fertility preservation options for patients about to undergo cancer therapy.
Hot Flash Treatment Strategies for Patients With Breast Cancer
Ahead of his presentation at the 39th Annual Miami Breast Cancer Conference, Charles L. Loprinzi, MD, highlights some non-estrogenic approaches to hot flash management for patients with breast cancer.
Systematic, Adaptable Symptom Management Is Long Overdue In Oncology Practice
Heidi Donovan, PhD, RN, comments on principles of symptom management that she believes need to be better implemented in clinical practice—particularly for patients with ovarian cancer.
Overcoming The Burden of Guilt as A Nurse
Janice Post-White, PhD, RN, FAAN, an oncology nurse and caregiver, discusses how she handled the guilt she felt following her son’s leukemia diagnosis.
Integrated Behavioral Health Vs Standard Practice: What’s The Difference?
A licensed clinical health psychologist with Allegheny Health Network discusses fully integrated behavioral health programs and how their design alleviates potential barriers to care that patients may experience.
Newly Approved Tebentafusp Requires Up-Front Active Toxicity Management in Melanoma
Tebentafusp, the first FDA-approved treatment option for patients with unresectable or metastatic uveal melanoma, may cause mild cytokine release syndrome, an expert explains.
More Than A “Side Effect”: Why Pediatric Hearing Loss Is So Detrimental
An expert discusses the consequences of cisplatin-induced hearing loss and ongoing research efforts to eliminate this associated risk for children receiving the treatment.
How Can Writing Help Process Cancer-Related Grief?
Janice Post-White, PhD, RN, FAAN, an oncology nurse and caregiver, comments on how the act of writing allowed her to process previously suppressed emotions.
Setting Boundaries Can Be a Challenge for Nurse Navigators
Janelle Wagner, RN, OCN, Senior Manager of Patient Navigation Program for Community Sites, highlights some challenges commonly associated with nurse navigation, and how nurses can overcome them.
Nurses Hold Power to Change Rhetoric Surrounding Electronic Smoking
Although the long-term effects of e-smoking are still unknown, the percentage of young people developing nicotine dependency is increasing, a Cancer Treatment Centers of America expert explains.
Expert Explains Significance of LAG-3 Inhibition in Novel Immunotherapies for Melanoma
LAG-3 represents a potentially relevant immune checkpoint pathway in melanoma treatment.
Confidence Is Key in Oncology Nurse Navigation
An expert from Seattle Cancer Care Alliance highlights key skills in nurse navigation.
Expert Explains Rationale Behind RELATIVITY-047 in Melanoma
Dr. Hussein Tawbi, MD, PhD, explains the rationale behind the RELATIVITY-047 trial in melanoma and how the LAG-3 findings could further revolutionize immunotherapy.
Nurses May Advise Patients on Immunotherapy to Increase Fiber Intake
An expert from The University of Texas MD Anderson Cancer Center offers advice on the best diet to enrich a patient’s microbiome and consequent immunotherapy response.
Diet and Probiotics Influence Immunotherapy Responses in Melanoma
An expert from The University of Texas MD Anderson Cancer Center highlights findings demonstrating the impact that diet and probiotics have in immunotherapy responses.
Oral Elacestrant Requires Patient Education in Metastatic ER+ Breast Cancer
Nausea and upper GI discomfort are frequently linked with use of the oral SERD.
Nursing Considerations for Using Selinexor in Multiple Myeloma
An expert from the Tisch Cancer Institute highlights the importance of medication adherence, nausea management, and proper hydration for patients being treated with selinexor for relapsed or refractory multiple myeloma.
Palliative Care Does Not Prevent Patients From Receiving Curative Treatment
The chair of the Institute of Pain and Palliative Care explains how the holistic approach of palliative care makes it a unique treatment modality.
Many Patients Are Under-Sedated During End-of-Life Cancer Care
David Hui, MD, MSc, from The University of Texas MD Anderson Cancer Center, discusses findings indicating that patients with agitated delirium may be under-sedated, in accordance with their personalized sedation goal.
Self-Awareness Is Critical in Treating Prescribing Patients With Cancer and Substance Abuse Disorders
Kathy Burns, MS, APRN-CNS, AGCNS-BC, of the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, comments on the importance of self-awareness as an oncology nurse when working to overcome one’s implicit bias.
Personal Bonds Make NP Fellowship Programs Advantageous Choice For Recent Graduates
Jessica MacIntyre, APRN, NP-C, AOCNP, explains how Hematology/Oncology Nurse Practitioner Fellowship at Sylvester Comprehensive Cancer Center prepares fellows for success.
Neoadjuvant Durvalumab Combination Misses Mark in EGFR+ NSCLC
Durvalumab Garners Similar OS, Albeit Varied PFS, Outcomes in EGFR+ and EGFR-Wildtype NSCLC Subgroups
Quizartinib Extends Overall Survival Across Multiple Subgroups in FLT3-ITD+ AML
Repotrectinib Showcases Early Intracranial Responses in Select ROS1+ NSCLC
2 Clarke Drive Cranbury, NJ 08512